{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T06:21:32Z","timestamp":1778048492648,"version":"3.51.4"},"reference-count":18,"publisher":"Informa UK Limited","issue":"8","license":[{"start":{"date-parts":[[2025,6,27]],"date-time":"2025-06-27T00:00:00Z","timestamp":1750982400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"name":"Takeda Pharmaceuticals U.S.A., Inc"}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Expert Review of Anti-infective Therapy"],"published-print":{"date-parts":[[2025,8,3]]},"DOI":"10.1080\/14787210.2025.2517344","type":"journal-article","created":{"date-parts":[[2025,6,6]],"date-time":"2025-06-06T12:15:00Z","timestamp":1749212100000},"page":"653-662","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":1,"title":["Real-world effectiveness and tolerability of post solid organ transplant patients with CMV switching from valganciclovir treatment to maribavir: analysis using lab-linked claims data in the United States"],"prefix":"10.1080","volume":"23","author":[{"given":"Krithika","family":"Rajagopalan","sequence":"first","affiliation":[{"name":"Anlitiks Inc","place":["Windermere, USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Bullano","sequence":"additional","affiliation":[{"name":"Takeda Pharmaceuticals U.S.A. Inc","place":["Lexington, USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniele","family":"Gelone","sequence":"additional","affiliation":[{"name":"Takeda Pharmaceuticals U.S.A. Inc","place":["Lexington, USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tien","family":"Bo","sequence":"additional","affiliation":[{"name":"Takeda Pharmaceuticals U.S.A. Inc","place":["Lexington, USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vamshidhar","family":"Taduka","sequence":"additional","affiliation":[{"name":"Anlitiks Inc","place":["Windermere, USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Safiuddin Shoeb","family":"Syed","sequence":"additional","affiliation":[{"name":"Anlitiks Inc","place":["Windermere, USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2025,6,27]]},"reference":[{"key":"e_1_3_6_3_1","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2020.00130"},{"key":"e_1_3_6_4_1","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiz454"},{"key":"e_1_3_6_5_1","doi-asserted-by":"publisher","DOI":"10.1111\/tid.13977"},{"key":"e_1_3_6_6_1","doi-asserted-by":"publisher","DOI":"10.6061\/clinics\/2015(07)09"},{"key":"e_1_3_6_7_1","doi-asserted-by":"publisher","DOI":"10.1097\/TP.0000000000005374"},{"key":"e_1_3_6_8_1","doi-asserted-by":"publisher","DOI":"10.3389\/ti.2023.11785"},{"key":"e_1_3_6_9_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.antiviral.2023.105623"},{"key":"e_1_3_6_10_1","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciae321"},{"key":"e_1_3_6_11_1","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiz493"},{"key":"e_1_3_6_12_1","doi-asserted-by":"publisher","DOI":"10.3390\/microorganisms8101516"},{"key":"e_1_3_6_13_1","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciab988"},{"key":"e_1_3_6_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmi.2022.07.001"},{"key":"e_1_3_6_15_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.antiviral.2019.01.011"},{"key":"e_1_3_6_16_1","doi-asserted-by":"publisher","DOI":"10.1128\/aac.02405-21"},{"key":"e_1_3_6_17_1","doi-asserted-by":"publisher","DOI":"10.1111\/tid.14070"},{"key":"e_1_3_6_18_1","doi-asserted-by":"publisher","DOI":"10.1097\/TP.0000000000001418"},{"key":"e_1_3_6_19_1","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiad293"},{"key":"e_1_3_6_20_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40121-022-00746-1"}],"container-title":["Expert Review of Anti-infective Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/14787210.2025.2517344","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T10:16:34Z","timestamp":1754043394000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/14787210.2025.2517344"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,27]]},"references-count":18,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2025,8,3]]}},"alternative-id":["10.1080\/14787210.2025.2517344"],"URL":"https:\/\/doi.org\/10.1080\/14787210.2025.2517344","relation":{},"ISSN":["1478-7210","1744-8336"],"issn-type":[{"value":"1478-7210","type":"print"},{"value":"1744-8336","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,27]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ierz20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ierz20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2025-05-07","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-06-04","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-06-27","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}